Is temporal artery biopsy essential in all cases of suspected giant cell arteritis?

被引:0
作者
Grossman, C. [1 ]
Barshack, I. [2 ]
Bornstein, G. [1 ,3 ]
Ben-Zvi, I. [1 ,4 ]
机构
[1] Chaim Sheba Med Ctr, Rheumatol Unit, IL-52621 Tel Hashomer, Israel
[2] Chaim Sheba Med Ctr, Dept Pathol, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Dept Internal Med D, IL-52621 Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Dept Internal Med F, IL-52621 Tel Hashomer, Israel
关键词
giant cell arteritis; temporal artery biopsy; ACR classification criteria; POLYMYALGIA-RHEUMATICA; CLINICAL SPECTRUM; CLASSIFICATION; CRITERIA; MANAGEMENT; DIAGNOSES; DISEASE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. Temporal artery biopsy (TAB) is performed in cases of suspected giant cell arteritis (GCA), and is the gold-standard for diagnosis of the disease. Current American College of Rheumatology (ACR) classification criteria may aid in the diagnosis of GCA. We aimed to assess whether TAB is essential in all cases of suspected GCA, or whether ACR criteria can replace the need for this procedure in some cases. Methods. Retrospective analysis of 216 patients who underwent TAB in a single hospital between 2000 and 2013. Pre-TAB and post-TAB ACR criteria were calculated. Sensitivity and specificity of ACR criteria for the diagnosis of GCA were assessed. Results. Overall, 55 patients had histological evidence of GCA. Out of 161 patients with negative TAB findings, 34 were diagnosed with GCA, and 127 were not diagnosed with GCA. Sensitivity of TAB for the diagnosis of GCA was 61.7%. Sensitivity and specificity of ACR criteria for diagnosis of GCA before performing TAB were 68.5% and 58%, respectively. Sensitivity and specificity of ACR criteria after performing TAB biopsy were 89.8% and 64.5%, respectively. Conclusion. Temporal artery biopsy should be performed in the majority of patients with suspected GCA, and may be obviated only in patients with a pre-TAB ACR score of <= 1. In all other cases, when GCA is suspected, ACR criteria should not be a substitute to TAB, as they are not highly specific.
引用
收藏
页码:S84 / S89
页数:6
相关论文
共 29 条
[1]  
Breuer GS, 2008, CLIN EXP RHEUMATOL, V26, P1103
[2]   Genetic component of giant cell arteritis [J].
David Carmona, F. ;
Gonzalez-Gay, Miguel A. ;
Martin, Javier .
RHEUMATOLOGY, 2014, 53 (01) :6-18
[3]   Temporal artery biopsy ... Who needs one? [J].
Davies, C. ;
Frost, B. ;
Eshan, O. ;
McLain, A. D. ;
Shandall, A. .
POSTGRADUATE MEDICAL JOURNAL, 2006, 82 (969) :476-478
[4]   Biopsy proven and biopsy negative temporal arteritis:: differences in clinical spectrum at the onset of the disease [J].
Duhaut, P ;
Pinède, L ;
Bornet, H ;
Demolombe-Ragué, S ;
Dumontet, C ;
Ninet, J ;
Loire, R ;
Pasquier, J .
ANNALS OF THE RHEUMATIC DISEASES, 1999, 58 (06) :335-341
[5]  
Gonzalez-Gay MA, 2005, J RHEUMATOL, V32, P1186
[6]   Giant cell arteritis - Disease patterns of clinical presentation in a series of 240 patients [J].
Gonzalez-Gay, MA ;
Barros, S ;
Lopez-Diaz, MJ ;
Garcia-Porrua, C ;
Sanchez-Andrade, A ;
Llorca, J .
MEDICINE, 2005, 84 (05) :269-276
[7]   Biopsy-negative giant cell arteritis: Clinical spectrum and predictive factors for positive temporal artery biopsy [J].
Gonzalez-Gay, MA ;
Garcia-Porrua, C ;
Llorca, J ;
Gonzalez-Louzao, C ;
Rodriguez-Ledo, P .
SEMINARS IN ARTHRITIS AND RHEUMATISM, 2001, 30 (04) :249-256
[8]   Epidemiology of Giant Cell Arteritis and Polymyalgia Rheumatica [J].
Gonzalez-Gay, Miguel A. ;
Vazquez-Rodriguez, Tomas R. ;
Lopez-Diaz, Maria J. ;
Miranda-Filloy, Jose A. ;
Gonzalez-Juanatey, Carlos ;
Martin, Javier ;
Llorca, Javier .
ARTHRITIS CARE & RESEARCH, 2009, 61 (10) :1454-1461
[9]   GIANT-CELL ARTERITIS IN MEDITERRANEAN COUNTRIES - COMMENT [J].
GONZALEZGAY, MA ;
ALONSO, MD ;
AGUERO, JJ ;
BAL, M ;
FERNANDEZCAMBLOR, B ;
SANCHEZANDRADE, A .
ARTHRITIS AND RHEUMATISM, 1992, 35 (10) :1249-1249
[10]  
HALL S, 1983, LANCET, V2, P1217